Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market & Industry Briefs

Executive Summary

Brief summaries of recent medtech market and industry developments. This month we cover what might be inhaled insulin's death knell, MetaCure's play in interventional diabetes and Novartis' deal with Alcon, and the US fracture fixation market.
Advertisement

Related Content

Market & Industry Briefs
Market & Industry Briefs
Novartis' New Kind of Pharma Deal
MetaCure Ushers in a New Era in Interventional Diabetes
Inhaled Insulin is Dead. Long Live Inhaled Insulin
Business and Technology Briefs
Business & Technology Briefs (11/2007)
Novartis Buys into New Pharma World Order

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT035180

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel